PQC: It “seems” this CovidFraud would never let me “go” folks! LOL!

Khalilah Mitchell – nurse warns against Corona vaccine

If You want more details and in depth, Please listen to this American Last Vagabond’s analysis:

4 volunteers develop FACIAL PARALYSIS after taking Pfizer Covid-19 jab, prompting FDA to recommend ‘surveillance for cases’

9 Dec, 2020 08:17 / Updated 18 days ago

4 volunteers develop FACIAL PARALYSIS after taking Pfizer Covid-19 jab, prompting FDA to recommend ‘surveillance for cases’

©  Pool via REUTERS / Ben Birchall

Follow RT on Four trial participants who received the Pfizer Covid-19 vaccine experienced facial paralysis, according to the Food and Drug Administration. The FDA said the issue should be monitored as the jab becomes more widely available.

The potentially concerning cases were revealed after the US drug regulator published an analysis of the Pfizer-BioNTech vaccine ahead of a meeting to consider emergency use authorization for the jab in the United States. 

According to the documents, Bell’s palsy, a form of temporary facial paralysis, was reported by four participants during phase 3 trials. The individuals had been administered the jab, and no members of the placebo group experienced similar adverse effects. 

The condition resembles a stroke, with most sufferers watching helplessly as one side of their face droops and their muscles go limp. In some rare situations, both sides of the face may become paralyzed. It is unclear what causes Bell’s palsy, although the temporary paralysis usually goes away on its own.  Read more Mass vaccination delayed in US and UK, as drug firms struggle to meet demand

However, the FDA claimed that the frequency of the health issue is “consistent with the expected background rate in the general population,” and added that there was no clear evidence linking the coronavirus vaccine to the unpleasant medical condition. Still, the federal regulator recommended “surveillance for cases of Bell’s palsy with deployment of the vaccine into larger populations.”

The FDA noted the “numerical imbalance” of Bell’s palsy cases among the vaccine and placebo groups, but said there were no other “non-serious adverse events” that showed a similar pattern.  

According to the documents, side effects are common but appear to be minor. Out of the trial participants, 84 percent experienced some kind of reaction. After receiving the jab, 63 percent of trial subjects reported fatigue and 55 percent said they suffered from headaches. Chills were reported by 32 percent of participants, 24 percent complained of joint pain and 14 percent developed a fever.

Overall, the jab appears to have received good marks from the FDA. In its report, the regulator said that the two-dose vaccine is about 50 percent effective even after just the first injection. The vaccine is believed to be 95 percent effective after the second dose, administered three weeks later. The FDA also found that the jab reduced the risk of severe Covid-19 symptoms after the first dose. 

On Tuesday, the United Kingdom became the first country in the world to begin administering the Pfizer-BioNTech vaccine to the general population. 

Coronavirus AstraZeneca vaccine: Volunteer dies during human trials

A volunteer taking part in the trial for AstraZeneca’s COVID-19 vaccine, which Australians could be given doses of, has died.

https://thefederalist.com/2020/10/22/washington-post-buries-facts-about-death-of-volunteer-in-covid-19-vaccine-trial/

Washington Post Buries Facts About Death Of Volunteer In COVID-19 Vaccine Trial

Washington Post Buries Facts About Death Of Volunteer In COVID-19 Vaccine Trial

October 22, 2020 By Jordan Davidson

The Washington Post posted an article to Twitter on Wednesday claiming that a “Volunteer in Oxford coronavirus vaccine trial dies.”

Volunteer in Oxford coronavirus vaccine trial dies https://t.co/xsp0iTPX4T

— The Washington Post (@washingtonpost) October 21, 2020

While the Twitter caption for the article is jarring and reads as a major cause for concern, once clicked on, the full headline reveals that this abbreviated spin is misleading.

“Volunteer in Oxford coronavirus vaccine trial dies, reportedly did not receive experimental vaccine,” the headline on the WaPo website reads.

The article goes on to note that the volunteer referred to in the tweet was reportedly in a control group in the trial that did not receive the vaccine. The Brazilian died after contracting COVID-19.

This important fact, however, doesn’t appear in the article until the third paragraph. The first two paragraphs, including the hook for the story, purposefully avoid this key fact.

“A Brazilian who participated in the clinical trial of an experimental coronavirus vaccine has died, officials here said Wednesday,” the article reads.

“Brazil’s National Health Surveillance Agency, which is overseeing multiple vaccine trials in a country suffering one of the world’s worst outbreaks, said the individual volunteered to receive the vaccine candidate developed by Oxford University and produced by AstraZeneca,” it continues.

Many Twitter users noted that this spin by the Post is misleading to readers, irresponsible, and injured the integrity of the story.

Wouldn’t be the worst to have this info all in the tweet copy to avoid scaring people unnecessarily about vaccines. https://t.co/vyei2dhdQD pic.twitter.com/316WjgQrqP

— Matt Whitlock (@mattdizwhitlock) October 21, 2020

Responsible journalism would have pointed out in the headline (or at least the tweet) that the volunteer had been given a placebo https://t.co/E2ducKQSgv

— David Cochrane (@davidcochrane) October 22, 2020

Very irresponsible that this tweet omits the fact that the volunteer was reportedly *in the control group* https://t.co/x9BCNfD4GE

— Gregg Carlstrom (@glcarlstrom) October 22, 2020

*who was in a control group and didn’t receive the vaccine

Pretty staggering how irresponsible this is. https://t.co/rzIKTws30F

— Ben Thompson (@benthompson) October 22, 2020

Pretty irresponsible to not include this in the tweet: “…the volunteer was in a control group that did not receive the experimental vaccine and died of covid-19.” https://t.co/a6BEQFbqqM

— Ryan Saavedra (@RealSaavedra) October 22, 2020

Misleading headline with an intention to spread despair. The volunteer who died was part of the control group, as in did not receive the vaccine https://t.co/IIpgJTYJfe

— Ram (@ramprasad_c) October 22, 2020

He got the placebo. Maybe mention that? https://t.co/V2sKaAeC9T

— Tim Fullerton (@TimFullerton) October 21, 2020

This anti-vaccine spin has been a popular talking point among media outlets and Democrats.

On Monday, New York Gov. Andrew Cuomo urged Americans to be “skeptical” of a vaccine manufactured and approved under the Trump Administration.

“You are going to say to the American people, now, here’s a vaccine, it is new, it was done quickly, but trust this federal administration and their health administration that it’s safe? And we’re not 100% sure of the consequences? I think it’s going to be a very skeptical American public about taking the vaccine and it should be.”

Democratic VP Nominee Kamala Harris also cast suspicion over a vaccine produced by the Trump administration during the vice presidential debate, saying she doesn’t trust the president enough to get the vaccine herself.

“If the public health professionals, if Dr. Fauci, if the doctors tell us that we should take it, I’ll be the first in line to take it. Absolutely,” Harris said. “If Donald Trump tells us to take it, I’m not taking it.”

A poll released by STAT-Harris shows that American willingness to get the COVID-19 vaccine is falling after these pushes by Democrats and their corporate media echo chambers have expressed skepticism of its safety and urged Americans to avoid it if approved.

According to the poll, 69 percent of the U.S. public said they would get the COVID-19 vaccine “as soon as a vaccine was available” in mid-August, but only 58 percent said the same thing in October. Jordan Davidson is a staff writer at The Federalist. She graduated from Baylor University where she majored in political science and minored in journalism.